Proton Therapy Market With Players Like ProTom, Hitachi, Mevion Medical Systems, IBA Worldwide, Varian Medical Systems, Philips, Sumitomo Heavy Industries, Mitsubishi Electric

“Proton Therapy”
Proton Therapy Market By Product (Equipment, Service), Type (Electron Beam, Proton Beam, Neutron Beam, Carbon Ion Beam, Alpha Particle Beam, Beta Particle Beam), Set-Up Systems (Single-Room Systems, Multi-Room Systems, Compact Systems), Indication, End-User, Geography

Proton therapy market is expected to rise from its initial estimated value of USD 1.13 billion in 2018 to a projected value of USD 3.56 billion by 2026, registering a CAGR of 15.34% in the forecast period of 2019-2026.

The market research report examines the structure of the global proton therapy market by covering different features, for example, the market size, drivers and restraints, supply-side situation, speculation situation, market portions, and the future market conjecture. The data accumulated in this market report depends on top-notch wellsprings of information. Aside from that, it additionally contains valuable market knowledge received from proton therapy industry experts and specialists. By giving nitty gritty experiences about the market, this report makes a solid base for in-depth examination, which features the highlights of development pursued by the proton therapy market throughout these years.

The proton therapy report utilizes explanatory tools, for example, SWOT analysis and Porters five forces analysis to distinguish the potential opportunities and glaring dangers in the worldwide proton therapy market. The report recognizes the ongoing mergers and acquisitions that have occurred in the proton therapy market. The report distinguishes the noticeable organizations working in this market and discusses the profiles of each. The facts and figures displayed in this report make a sound base for making the right and fruitful business choices. With a thorough examination of the ongoing patterns in the market, the proton therapy market report helps the current also as new players in the market to make choices that will guarantee the accomplishment of their business over the long haul.

Get Free Sample Report of This Market Information: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-proton-therapy-market

This rise in market value can be attributed to growth of the population suffering from cancer. Top players are

  • Mevion Medical Systems
  • ProTom International
  • Hitachi, Ltd.
  • IBA Worldwide
  • Sumitomo Heavy Industries, Ltd.
  • Varian Medical Systems, Inc.
  • Koninklijke Philips N.V.
  • Mitsubishi Electric Corporation
  • Fermilab

Other are Optivus Proton Therapy, Inc., Elekta AB (pub) with Advanced Oncotherapy are few of the major competitors present in the market. Proton therapy is a pharmaceutical technique which involves the treatment of cancerous cells and tumor, it involves the usage of radiation devices and focused radiation therapy along with accelerated protons which act as the radiation source. Through proton therapy, physicians can completely focus the radiation therapy on only the cancerous cells rather than damaging the healthy tissues and organs in close quarters of the targeted area.

Market Drivers

  • Increasing investments and funding for advancements in technologies of treatment in cancer treatments as well as increasing the establishment of proton therapy centers; this factor is expected to act as a driver for the market growth
  • Innovations and advancements in the therapeutic systems of cancer treatments and advancements in proton therapy product offerings; this factor is expected to act as a driver for the market growth

 Get TOC For Full Analysis Of Report: https://databridgemarketresearch.com/toc/?dbmr=global-proton-therapy-market

 Market Restraint

  • Requirement of large funds initially for establishing and usage of proton therapy is expected to restrain the market growth

 Segmentation: Global Proton Therapy Market

  • By Product
    • Equipment
    • Service
  • By Type
    • Electron Beam
    • Proton Beam
    • Neutron Beam
    • Carbon Ion Beam
    • Alpha Particle Beam
    • Beta Particle Beam
  • By Set-Up Systems
    • Single-Room Systems
    • Multi-Room Systems
    • Compact Systems
  • By Indication
    • Pediatric Cancer
    • Pelvic Cancer
    • Sarcoma
    • Prostate Cancer
    • Lung Cancer
    • Bone & Soft Tissue Cancer
    • Gastro-Intestinal Cancer
    • Liver Cancer
    • Brain Tumor
    • Central Nervous System
    • Eye Cancer
    • Head & Neck Cancer
    • Others
  • Renal Cell Carcinoma
  • Cervical
  • Gastric
  • Lymphoma
  • By End-User
    • Hospitals
    • Ambulatory Surgical Centers
    • Others
  • By Geography
    • North America
  • US.
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Turkey
  • Belgium
  • Netherlands
  • Switzerland
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • South Korea
  • India
  • Australia
  • Singapore
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Rest of Asia Pacific
  • Middle East & Africa
  • South Africa
  • Egypt
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Rest of Middle East & Africa

 Global proton therapy market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of proton therapy market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

 Key Developments in the Market:

  • In January 2019, Apollo Hospitals Enterprise Ltd. announced the launch of South Asia’s first proton therapy situated in Tamil Nadu, India. The center equipped with pencil-beam scanning technology offering which offers the highest precision of therapy.
  • In September 2018, Hitachi, Ltd. announced that they had received an order from Tokushukai Medical Group for usage in Shonan Kamakura Advanced Medical Center for Hitachi’s compact proton therapy system. The dedicated system is expected to be completed by September 2020.
  • In January 2018, Hitachi, Ltd. announced that they had received US FDA 510(k) clearance for their commercialization of “Real Time Image Gating System for Proton Beam Therapy Systems”. This clearance will allow for patients in United States to be treated with cutting-edge motion management and enhanced Spot Scanning identification technology.

 Want Full Report? Enquire Here: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-proton-therapy-market

About Us

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://databridgemarketresearch.com/reports/global-proton-therapy-market/